• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches  
Title Created Date
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages 24 June 2025
Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects 27 May 2025
Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma 09 May 2025
Hormones and growth factors regulate telomerase activity in ageing and cancer 16 April 2025
Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals 03 April 2025
Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects 20 January 2025
Extrapineal melatonin in pathology: new perspectives for diagnosis, prognosis and treatment of illness 16 May 2024
Evaluation of gene expression in human lymphocytes activated in the presence of melatonin 16 May 2024
Melatonin: therapeutic and clinical utilization 17 March 2024
Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin 11 February 2024
Display # 

Page 3 of 111

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
  • Updated perspectives on vitamin D deficiency, screening, supplementation and clinical guidance
  • Melatonin: an inhibitor of breast cancer
  • All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
  • Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice
  • Effect of oral melatonin on sleep quality, fatigue, and caregiver sleep perception in patients with head and neck cancer: A randomized double-blind placebo-controlled trial
  • Mechanisms Underlying Tumor Suppressive Properties of Melatonin
  • Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis
  • Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
  • A case control study to determine the frequency of vitamin d deficiency in carcinoma breast in females of local population of Rawalpindi and Islamabad area
  • In vitro and in vivo antitumor activity of melatonin receptor agonists
  • Proteoformics-driven new concept of human growth hormone in clinical endocrinology
  • The role of melatonin in colorectal cancer treatment: a comprehensive review
  • The Role of Melatonin in Colorectal Cancer
  • Ameliorative effects of melatonin on radiotherapy-induced apoptotic and inflammatory responses in rat parotid gland
  • The role of melatonin in immuno-enhancement: potential application in cancer
  • Circulating neuroendocrine markers in patients with prostate carcinoma
  • Somatostatin and the treatment of cancer

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer